Brief: Interpace Enters Strategic Partnership Agreement With Genecast Biotechnology To Partner With Biopharma Solutions In China
Sept 16 (Reuters) - Interpace Diagnostics Group Inc
IDXG.O :
* INTERPACE ENTERS STRATEGIC PARTNERSHIP AGREEMENT WITH
GENECAST
BIOTECHNOLOGY TO PARTNER WITH BIOPHARMA SOLUTIONS IN CHINA
* INTERPACE DIAGNOSTICS GROUP INC - INTERPACE BIOPHARMA WILL
PERFORM SERVICES WORLDWIDE EXCEPT IN PRC, WHILE GENECAST WILL
PROVIDE SERVICES IN PRC
Source text for Eikon: ID:nGNXJ3gl8
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million